David L Chan — ASN Events

David L Chan — ASN Events

David Chan

Royal North Shore Hospital, NSW, Australia

This delegate is presenting an abstract at this event.

Presentations this author is a contributor to:

Symptom burden of Australia and New Zealand (ANZ) patients with Neuroendocrine Tumours (NET) (#348)

‘Rethinking REAL-2: Real-life outcomes from an Australian retrospective audit of patients with metastatic oesophago-gastric adenocarcinoma (mOGC)’ (#219)

Claudia E.A Stretch

A retrospective study of dual ¹⁸F-fluorodeoxyglucose/⁶⁸Gallium DOTATATE (FDG/⁶⁸Ga-DOTATATE) positron emission tomography (PET) grading and its prognostic value in metastatic pancreatic neuroendocrine tumours (PNET) (#349)

Experience of Australia and New Zealand (ANZ) patients with neuroendocrine tumours (NET) treated at a NET specialist centre: Results of a national survey and the Royal North Shore experience (#350)